All Public Health articles – Page 3
-
NewsVirologists issue warning on rapidly escalating measles crisis in the U.S. and worldwide
The Global Virus Network (GVN) is sounding the alarm over a sharp resurgence of measles cases in the United States and globally. This resurgence, fueled by falling vaccination rates, threatens to erode decades of public health progress.
-
NewsPenicillin allergy testing needed to fight antibiotic resistance
Removing incorrect penicillin allergy labels on GP records could combat antibiotic resistance and save lives, an NIHR-funded clinical trial has found.
-
NewsReview suggests ending adult boosters for tetanus, diphtheria
The United States could safely drop tetanus and diphtheria booster shots for adults and save an estimated $1 billion a year, according to a new review. The safety and savings depend on maintaining strong childhood vaccination rates, researchers emphasized.
-
NewsBeyond health: The political effects of infectious disease outbreaks
A new study gives empirical evidence that individuals who experienced an infectious disease outbreak show significantly less trust in the political establishment.
-
NewsHepatitis C treatment is not reaching some at-risk populations, studies show
Studies reveal that two vulnerable populations — children and recently pregnant women — face disparities in access to treatment for hepatitis C infection. Without treatment, they are at risk of long-term adverse health outcomes such as cirrhosis, liver cancer and death.
-
NewsCohort data from Denmark show real-world evidence of stable protection against HPV-related cervical cancer
Denmark has been offering free vaccination against human papillomavirus (HPV) to girls since 2008. New data show vaccination has effectively reduced infections with cancerogenic HPV 16/18 types covered by the vaccine, indicating population immunity.
-
NewsComprehensive review sheds light on rare blood clotting syndrome linked to COVID-19 vaccines
A new analysis has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT). The findings confirm a higher risk of arterial and venous thrombosis after COVID-19 infection compared to vaccination.
-
NewsProtecting the most vulnerable: ECDC recommendations to address ongoing local transmission of diphtheria
A new ECDC Rapid Risk Assessment highlights how ongoing circulation of diphtheria caused by Corynebacterium diphtheriae may affect some populations who are more vulnerable to infection and issues recommendations to protect those most at risk.
-
NewsEpidemiology, achievements, and challenges in the elimination of hepatitis B in China
A new review outlines China’s progress towards meeting the World Health Organization (WHO) hepatitis B virus 2030 elimination targets, identifies persistent gaps, and highlights strategies for achieving HBV elimination.
-
NewsVaccination support program reduces pneumonia-related mortality by 25 per cent among the elderly
Findings based on efforts in Sera Town, Japan showed the pneumococcal vaccination support program reversed the previously increasing trend in pneumonia mortality rate in the community.
-
NewsAntibiotics are failing in many countries in Africa, new study reveals
The largest retrospective study on resistance to antibiotics in Africa highlights the need for major investments to enhance laboratory capabilities and healthcare access.
-
NewsInternational comparison reveals gender differences in antimicrobial resistance
A recent study analysed the DNA map of more than 14,000 gut metagenomes in a global dataset and found differences in antibiotic resistance between genders. In high-income countries, women had more antibiotic resistance genes than men.
-
NewsGlobal action urgently needed to tackle antimicrobial resistance, experts warn
Scientists have called for urgent changes to the way new antibiotics are developed to address the growing problem of antimicrobial resistance (AMR). They outline the scientific, economic, and regulatory barriers that are slowing progress.
-
NewsAn oral cholera vaccination campaign aims to reach more than 2.6 million people in Sudan’s Khartoum State
A 10-day reactive oral cholera vaccination campaign, launched on 10 June in 5 localities in Sudan’s Khartoum State, aims to protect more than 2.6 million people aged 1 year and above from cholera infection, interrupt transmission and help contain the cholera outbreak.
-
News2 million Americans with hepatitis C at risk if Supreme Court cancels free preventative care, study finds
A ruling overturning the Affordable Care Act (ACA) coverage mandate has the potential to dramatically change the landscape for early detection and treatment of hepatitis C virus in the U.S., according to a new paper.
-
NewsGeographic bias in virus naming: Lessons from coronavirus show it’s better to act early
A new study highlights the need to avoid geographically-based naming right from the outset of a pandemic. It analyzes the impact of the WHO’s introduction of the Covid nomenclature based on Greek letters - Alpha, Beta, Delta, etc.
-
NewsSHEA affirms trust in ACIP and supports science-based vaccine policy
Public health experts have commented on the removal by the US Department of Health and Human Services (HHS) of all 17 members of the Advisory Committee on Immunization Practices (ACIP), which advises the Centers for Disease Control and Prevention (CDC) on the use of vaccines in the US.
-
NewsWHO announces that mpox remains a public health emergency of international concern
WHO Director-General Dr Tedros Adhanom Ghebreyesus has announced that the mpox upsurge continues to meet the criteria of a public health emergency of international concern (PHEIC) set forth in the International Health Regulations (IHR).
-
NewsNew study reveals global warming accelerates antibiotic resistance in soils
A new international study has revealed that climate change is accelerating the rate of development and global abundances of antibiotic resistance bacteria in soils.
-
NewsNew AI reimagines infectious disease forecasting
A new AI tool to predict the spread of infectious disease outperforms existing state-of-the-art forecasting methods. The tool could revolutionize how public health officials predict, track and manage outbreaks of infectious diseases including flu and COVID-19.